Literature DB >> 18184693

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

Natalie J Beveridge1, Paul A Tooney, Adam P Carroll, Erin Gardiner, Nikola Bowden, Rodney J Scott, Nham Tran, Irina Dedova, Murray J Cairns.   

Abstract

Analysis of global microRNA (miRNA) expression in postmortem cortical grey matter from the superior temporal gyrus, revealed significant up-regulation of miR-181b expression in schizophrenia. This finding was supported by quantitative real-time RT-PCR analysis of miRNA expression in a cohort of 21 matched pairs of schizophrenia and non-psychiatric controls. The implications of this finding are substantial, as this miRNA is predicted to regulate many target genes with potential significance to the development of schizophrenia. They include the calcium sensor gene visinin-like 1 (VSNL1) and the ionotropic AMPA glutamate receptor subunit (GRIA2), which were found to be down-regulated in the same cortical tissue from the schizophrenia group. Both of these genes were also suppressed in miR-181b transfected cells and shown to contain functional miR-181b miRNA recognition elements by reporter gene assay. This study suggests altered miRNA levels could be a significant factor in the dysregulation of cortical gene expression in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184693     DOI: 10.1093/hmg/ddn005

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  153 in total

Review 1.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 2.  Heterogeneity and individuality: microRNAs in mental disorders.

Authors:  Leif G Hommers; Katharina Domschke; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2014-11-14       Impact factor: 3.575

3.  Association study of H2AFZ with schizophrenia in a Japanese case-control sample.

Authors:  Daisuke Jitoku; Naoki Yamamoto; Yoshimi Iwayama; Tomoko Toyota; Momo Miyagi; Takeshi Enokida; Yuri Tasaka; Masakazu Umino; Asami Umino; Akihito Uezato; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Tasuku Hashimoto; Nobuhisa Kanahara; Akeo Kurumaji; Takeo Yoshikawa; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2014-11-13       Impact factor: 3.575

4.  Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons.

Authors:  Reuben Saba; Peter H Störchel; Ayla Aksoy-Aksel; Frauke Kepura; Giordano Lippi; Tim D Plant; Gerhard M Schratt
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

Review 5.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

6.  In vivo microRNA detection and quantitation in cerebrospinal fluid.

Authors:  Juan A Gallego; Marc L Gordon; Kierstyn Claycomb; Mahima Bhatt; Todd Lencz; Anil K Malhotra
Journal:  J Mol Neurosci       Date:  2012-03-09       Impact factor: 3.444

Review 7.  MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction.

Authors:  Bin Xu; Pei-Ken Hsu; Maria Karayiorgou; Joseph A Gogos
Journal:  Neurobiol Dis       Date:  2012-03-03       Impact factor: 5.996

Review 8.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

9.  Transcriptional profiling reveals that C5a alters microRNA in brain endothelial cells.

Authors:  Michael T Eadon; Alexander Jacob; Patrick N Cunningham; Richard J Quigg; Joe G N Garcia; Jessy J Alexander
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

Review 10.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.